-
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: A multinational, individual participant-level analysis
Abdelhak, A., Bachhuber, F., Ning, K., Benkert, P., John Boscardin, W., Maleska MacEski, A., Schaedelin, S., Achtnichts, L., Finkener, S., Lalive, P. H., Uginet, M., Pot, C., du Pasquier, R., Hoepner, R., Chan, A., Gobbi, C., Zecca, C., Müller, S., Roth, P. & Granziera, C. & 56 others, , 2025, (E-pub ahead of print) In: J. Neurol. Neurosurg. Psychiatry. jnnp-2025-335831.Research output: Contribution to journal › Article* › Academic › peer-review
-
Impact of serum neurofilament light on clinical decisions in a tertiary multiple sclerosis clinic
van Lierop, Z. Y. G., Wessels, M. H. J., Lekranty, W. M. L., Moraal, B., Hof, S. N., Hogenboom, L., de Jong, B. A., Meijs, N., Mensing, L. A., van Oosten, B. W., Sol, N., van Kempen, Z. L. E., Vermunt, L., Willems, M. J., Strijbis, E. M. M., Uitdehaag, B. M. J., Killestein, J. & Teunissen, C. E., Nov 2024, In: Multiple Sclerosis Journal. 30, 13, p. 1620-1629 10 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Serum neurofilament light and glial fibrillary acidic protein levels are not associated with wearing-off symptoms in natalizumab-treated multiple sclerosis patients
Toorop, A. A., Wessels, M. H. J., Boonkamp, L., Gelissen, L. M. Y., Hoitsma, E., Zeinstra, E. M. P., van Rooij, L. C., van Munster, C. E. P., Vennegoor, A., Mostert, J. P., Wokke, B. H. A., Kalkers, N. F., Hoogervorst, E. L. J., van Eijk, J. J. J., Roosendaal, C. M., Kragt, J. J., Eurelings, M., van Genugten, J., Nielsen, J. & Sinnige, L. G. F. & 12 others, , Nov 2024, In: Multiple Sclerosis Journal. 30, 13, p. 1683-1688 6 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
